vs
Sarepta Therapeutics, Inc.（SRPT）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
Sarepta Therapeutics, Inc.的季度营收约是世纪互联的1.0倍（$369.6M vs $362.7M），世纪互联净利率更高（-10.7% vs -111.5%，领先100.9%），Sarepta Therapeutics, Inc.自由现金流更多（$127.6M vs $-193.1M），过去两年世纪互联的营收复合增速更高（17.4% vs 1.4%）
Sarepta Therapeutics是一家总部位于美国马萨诸塞州剑桥的生物医药企业，专注于医学研究与药物研发。公司成立于1980年，前身为AntiVirals，后续先后更名为AVI BioPharma及现名，截至2023年已有四款获批上市药物，在相关疾病治疗领域深耕技术创新。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
SRPT vs VNET — 直观对比
营收规模更大
SRPT
是对方的1.0倍
$362.7M
净利率更高
VNET
高出100.9%
-111.5%
自由现金流更多
SRPT
多$320.7M
$-193.1M
两年增速更快
VNET
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $369.6M | $362.7M |
| 净利润 | $-412.2M | $-38.7M |
| 毛利率 | — | 20.9% |
| 营业利润率 | -111.4% | 0.5% |
| 净利率 | -111.5% | -10.7% |
| 营收同比 | -42.1% | — |
| 净利润同比 | -359.2% | — |
| 每股收益（稀释后） | $-3.92 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SRPTVNET
| Q4 25 | $369.6M | — | ||
| Q3 25 | $370.0M | $362.7M | ||
| Q2 25 | $513.1M | — | ||
| Q1 25 | $611.5M | $309.5M | ||
| Q4 24 | $638.2M | — | ||
| Q3 24 | $429.8M | $302.2M | ||
| Q2 24 | $360.5M | $274.4M | ||
| Q1 24 | $359.5M | $262.9M |
净利润SRPTVNET
| Q4 25 | $-412.2M | — | ||
| Q3 25 | $-50.6M | $-38.7M | ||
| Q2 25 | $196.9M | — | ||
| Q1 25 | $-447.5M | $-2.4M | ||
| Q4 24 | $159.0M | — | ||
| Q3 24 | $33.6M | $-2.1M | ||
| Q2 24 | $6.5M | $-1.1M | ||
| Q1 24 | $36.1M | $-22.0M |
毛利率SRPTVNET
| Q4 25 | — | — | ||
| Q3 25 | 59.3% | 20.9% | ||
| Q2 25 | 70.3% | — | ||
| Q1 25 | 77.5% | 25.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 78.7% | 23.2% | ||
| Q2 24 | 87.6% | 21.3% | ||
| Q1 24 | 85.9% | 21.6% |
营业利润率SRPTVNET
| Q4 25 | -111.4% | — | ||
| Q3 25 | -27.9% | 0.5% | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | -49.1% | 0.1% | ||
| Q4 24 | 25.3% | — | ||
| Q3 24 | 5.2% | 24.5% | ||
| Q2 24 | -0.2% | 0.2% | ||
| Q1 24 | 9.7% | 0.2% |
净利率SRPTVNET
| Q4 25 | -111.5% | — | ||
| Q3 25 | -13.7% | -10.7% | ||
| Q2 25 | 38.4% | — | ||
| Q1 25 | -73.2% | -0.8% | ||
| Q4 24 | 24.9% | — | ||
| Q3 24 | 7.8% | -0.7% | ||
| Q2 24 | 1.8% | -0.4% | ||
| Q1 24 | 10.0% | -8.4% |
每股收益（稀释后）SRPTVNET
| Q4 25 | $-3.92 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | $1.89 | — | ||
| Q1 25 | $-4.60 | — | ||
| Q4 24 | $1.56 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.37 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $939.6M | $492.1M |
| 总债务越低越好 | $829.0M | — |
| 股东权益账面价值 | $1.1B | $890.8M |
| 总资产 | $3.3B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.73× | — |
8季度趋势，按日历期对齐
现金及短期投资SRPTVNET
| Q4 25 | $939.6M | — | ||
| Q3 25 | $851.0M | $492.1M | ||
| Q2 25 | $800.1M | — | ||
| Q1 25 | $522.8M | $544.3M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.2B | $219.5M | ||
| Q2 24 | $1.5B | $247.2M | ||
| Q1 24 | $1.4B | $246.9M |
总债务SRPTVNET
| Q4 25 | $829.0M | — | ||
| Q3 25 | $140.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
股东权益SRPTVNET
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.3B | $890.8M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.1B | $927.8M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.2B | $902.9M | ||
| Q2 24 | $1.1B | $900.6M | ||
| Q1 24 | $961.2M | $895.1M |
总资产SRPTVNET
| Q4 25 | $3.3B | — | ||
| Q3 25 | $3.5B | $6.1B | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $3.5B | $5.4B | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $3.6B | $4.3B | ||
| Q2 24 | $3.4B | $4.0B | ||
| Q1 24 | $3.2B | $3.9B |
负债/权益比SRPTVNET
| Q4 25 | 0.73× | — | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.01× | 1.28× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $131.2M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $127.6M | $-193.1M |
| 自由现金流率自由现金流/营收 | 34.5% | -53.2% |
| 资本支出强度资本支出/营收 | 1.0% | 84.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-307.5M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流SRPTVNET
| Q4 25 | $131.2M | — | ||
| Q3 25 | $-14.6M | $113.8M | ||
| Q2 25 | $261.3M | — | ||
| Q1 25 | $-583.4M | $27.0M | ||
| Q4 24 | $92.0M | — | ||
| Q3 24 | $-70.7M | $108.3M | ||
| Q2 24 | $14.9M | $55.8M | ||
| Q1 24 | $-242.1M | $37.1M |
自由现金流SRPTVNET
| Q4 25 | $127.6M | — | ||
| Q3 25 | $-37.5M | $-193.1M | ||
| Q2 25 | $229.5M | — | ||
| Q1 25 | $-627.1M | $-220.0M | ||
| Q4 24 | $54.0M | — | ||
| Q3 24 | $-108.0M | $-95.0M | ||
| Q2 24 | $-14.2M | $-81.6M | ||
| Q1 24 | $-274.5M | $-102.2M |
自由现金流率SRPTVNET
| Q4 25 | 34.5% | — | ||
| Q3 25 | -10.1% | -53.2% | ||
| Q2 25 | 44.7% | — | ||
| Q1 25 | -102.5% | -71.1% | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | -25.1% | -31.4% | ||
| Q2 24 | -3.9% | -29.8% | ||
| Q1 24 | -76.4% | -38.9% |
资本支出强度SRPTVNET
| Q4 25 | 1.0% | — | ||
| Q3 25 | 6.2% | 84.6% | ||
| Q2 25 | 6.2% | — | ||
| Q1 25 | 7.1% | 79.8% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 8.7% | 67.3% | ||
| Q2 24 | 8.1% | 50.1% | ||
| Q1 24 | 9.0% | 53.0% |
现金转化率SRPTVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.33× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 2.31× | — | ||
| Q1 24 | -6.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SRPT
| Pmo Products | $202.5M | 55% |
| Elevidys | $110.4M | 30% |
| Other | $56.7M | 15% |
VNET
暂无分部数据
